Plain-English translation of NCT06439277 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called , given as a weekly injection, to see if it can help teenagers with obesity lose weight and improve related health problems like high blood pressure, prediabetes, or high triglycerides. The study will compare to a placebo (a fake injection with no active medicine) to understand how well and how safely the medication works in young people.
Obesity in teenagers often comes with serious health complications, and current treatment options are limited. Researchers want to know if this medication, which has shown promise in adults, can safely and effectively help teenagers manage their weight and the health problems that come with it.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive either the weekly injection or a placebo injection — neither you nor the research team will know which one at first. You'll visit the study clinic regularly for injections, blood tests, and check-ins to see how the treatment is working and to monitor for any side effects. The study will track your weight, blood pressure, and other health markers over time to see if the medication helps.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
United States